Therapies

#Antibodies #Covid-19 #Drug development #Drug discovery #Therapies #Vaccines

Covid-19 response speed sets a new standard in drug discovery

    This paid-for advertorial by Berkeley Lights appeared in DDW Volume 22, Issue 2 – Spring 2021 The Covid-19 pandemic has illuminated how a coordinated response to infectious diseases can result in the development and commercialisation of novel vaccines and therapies at record pace. Several therapeutic antibodies and vaccine… Read More

#Covid-19 #Exclusive Content

#Covid-19 #Immunology / Virology & Vaccines #Life sciences #Oncology #Therapies

The life sciences industry has learned a lot from COVID-19, but there’s more to be done

By Dr Steve Arlington, President, The Pistoia Alliance COVID-19 has dealt the life sciences a host of challenges, but it’s also been the catalyst for positive change. As the industry has turned its resources towards developing critical vaccines and therapies, organisations, governments, regulators, researchers and academia have come together in… Read More

#Editor's Choice #Exclusive Content #News #Opinion